Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: L'Oreal SA (LRLCY) - L'Oreal SA currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with strong market outperformance [4] Price Performance - Over the past week, L'Oreal shares increased by 1.9%, while the Zacks Consumer Products - Staples industry rose by 3.92% [6] - In a longer timeframe, L'Oreal's monthly price change is 2.49%, outperforming the industry's 0.06% [6] - Over the last quarter, L'Oreal shares have risen by 15.68%, and over the past year, they are up 33.91%, compared to the S&P 500's increases of 1.65% and 15.6%, respectively [7] Trading Volume - The average 20-day trading volume for L'Oreal is 217,340 shares, which serves as a price-to-volume baseline for assessing stock performance [8] Earnings Outlook - In the past two months, three earnings estimates for L'Oreal have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $3.15 to $3.41 [10] - For the next fiscal year, three estimates have also moved upwards without any downward revisions [10]

Core Viewpoint - Sanofi has appointed Belén Garijo as its new CEO, replacing Paul Hudson, amid challenges in the vaccine market and a stalled turnaround since Hudson's leadership began in 2019 [1]. Company Overview - Belén Garijo, aged 65, has a 15-year history with Sanofi, previously serving as vice president of pharmaceutical operations for Europe and Canada and as a member of the executive committee [1]. - Garijo played a significant role in integrating Sanofi's rare diseases unit, Genzyme, in the U.S. [1]. Previous Experience - Prior to her appointment at Sanofi, Garijo was the CEO of Merck KGaA, where she managed the company through turbulent market conditions influenced by the COVID-19 pandemic and oversaw strategic acquisitions and divestitures [1]. - Her tenure at Merck KGaA was marked by a mixed track record in drug development, with the company facing several setbacks during her leadership [1]. Board Memberships - Garijo served on the board of L'Oreal from 2014 to 2024 and currently holds a position on the board of Spanish lender BBVA [1]. Market Reaction - Following the announcement of Garijo's appointment, Sanofi's shares fell nearly 3% by 08:45 GMT on the day of the news [1].

Economic Indicators - The Federal Reserve is expected to cut the Fed funds rate by 25 basis points to a range of 3.50% to 3.75% due to concerns over the jobs market and inflation [1] - The core PCE price index rose +0.2% month-over-month and +2.8% year-over-year in September, slightly below expectations [3] - U.S. personal spending increased by +0.3% month-over-month, while personal income grew by +0.4% month-over-month, exceeding expectations [3] - The German October Industrial Production rose +1.8% month-over-month, significantly above expectations of +0.2% [10] Market Performance - Wall Street's major equity averages ended positively, with Ulta Beauty surging over +12% after strong Q3 results and raised guidance [4] - Micron Technology and GlobalFoundries saw gains of over +4% and +3% respectively, while Warner Bros. Discovery climbed more than +6% following Netflix's acquisition announcement [4] - In pre-market trading, Tesla fell over -1% after a downgrade, while Confluent soared more than +28% amid acquisition talks [16] Corporate Earnings - Several prominent companies, including Broadcom, Oracle, and Adobe, are set to release quarterly results this week [7] - Carvana is expected to be added to the S&P 500 index on December 22nd, leading to an over +8% rise in pre-market trading [17] International Developments - China's November Trade Balance stood at $111.68 billion, exceeding expectations of $105 billion, with exports rising +5.9% year-over-year [12] - Japan's economy contracted more than initially estimated in Q3, with a revised annualized GDP of -2.3% quarter-over-quarter [14]